Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Data presented at ICAAC indicate efficacy of Sch-56592 in leishmaniasis and phaeohyphomycosis

Sep. 29, 1998

In vivo efficacy and toxicity studies presented at ICAAC for T-3811ME

Sep. 29, 1998

Zeneca's CysLT1 antagonist shows potential for once-daily dosing; efficacy studies warranted

Sep. 29, 1998

V-11294A: an orally active PDE4 inhibitor undergoes testing in healthy volunteers

Sep. 29, 1998

Profile of new carbapenem antibiotic selected for activity against resistant pathogens

Sep. 29, 1998

Cubist presents favorable efficacy data for daptomycin at ICAAC

Sep. 29, 1998

Basic and clinical trials of S-1090 reported at ICAAC

Sep. 28, 1998

Enhancin peptides restore sensitivity to antibiotics in multidrug-resistant bacteria

Sep. 28, 1998

Clinafloxacin in the treatment of intraabdominal infections

Sep. 28, 1998

Preclinical data and clinical findings reported for Lilly echinocandin

Sep. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.